Scandion Oncology strengthens executive leadership appointing Bo Rode Hansen as CEO and Nils Brünner as new CSO
Scandion Oncology appoints Bo Rode Hansen as new President & CEO and co-founder Nils Brünner as new CSO to strengthen executive leadership, and secure corporate- and pipeline development towards upcoming value inflection points for Scandion Oncology.Scandion Oncology is pleased to announce that Bo Rode Hansen from October 1[st] is appointed President & CEO of the company. This planned evolution in the leadership of Scandion Oncology is executed to allow co-founder, Nils Brünner to focus his time, and world-renowned oncology expertise on the continued clinical development of our pipeline and